RSS
GH icon

Rosenblum Silverman Sutton’s Guardant Health GH Stock Holding History

Rosenblum Silverman Sutton’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,745
Closed -$877K – 74
2022
Q2 		$877K Sell
21,745
-2,710
-11% -$134K 0.29% 50
2022
Q1 		$1.62M Sell
24,455
-1,160
-5% -$79.4K 0.41% 44
2021
Q4 		$2.56M Buy
+25,615
New +$2.65M 0.58% 43

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Rosenblum Silverman Sutton's GH Position: Q3 2022 in Review

Rosenblum Silverman Sutton sold out of Guardant Health (GH) in Q3 2022, closing a stake of 21,745 shares — an estimated $877K sold.

Rosenblum Silverman Sutton first reported a position in GH in Q4 2021 and held it in 3 quarters. The position peaked at $2.56M in Q4 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • Rosenblum Silverman Sutton reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
  • Rosenblum Silverman Sutton sold 21,745 Guardant Health shares in Q3 2022, an estimated $877K.
  • Rosenblum Silverman Sutton first reported a position in Guardant Health in Q4 2021 and held it in 3 quarters.
  • Rosenblum Silverman Sutton's Guardant Health position peaked at $2.56M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Rosenblum Silverman Sutton's 13F filing for Q3 2022, filed 14 Nov 2022.